Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of topical analgesic cataplasms for osteoarthritis
ChiCTR2300072504Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of loxoprofen and flurbiprofen in osteoarthritis (OA) (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Total response rate. Started May 2023; status: recruiting.
02
Drugs
loxoprofenflurbiprofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300072504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072504.